Found: 43
Select item for more details and to access through your institution.
Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Using Risk Stratification to Optimize Mammography Screening in Chinese Women.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 4, p. 1, doi. 10.1093/jncics/pkab060
- By:
- Publication type:
- Article
Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12 , 93.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 1, p. 93, doi. 10.3390/life12010093
- By:
- Publication type:
- Article
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2271, doi. 10.3390/cancers15082271
- By:
- Publication type:
- Article
Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1251, doi. 10.3390/cancers14051251
- By:
- Publication type:
- Article
Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1511, doi. 10.3390/cancers13071511
- By:
- Publication type:
- Article
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 533, doi. 10.3390/cancers12030533
- By:
- Publication type:
- Article
DC-SIGN and L-SIGN: the SIGNs for infection.
- Published in:
- Journal of Molecular Medicine, 2008, v. 86, n. 8, p. 861, doi. 10.1007/s00109-008-0350-2
- By:
- Publication type:
- Article
Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 1, p. 72, doi. 10.3390/biom12010072
- By:
- Publication type:
- Article
A Case of Primary Hepatic Neuroendocrine Tumor and Literature Review.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 90, doi. 10.1159/000510935
- By:
- Publication type:
- Article
Significance of the myxovirus resistance A (MxA) gene -123C>a single-nucleotide polymorphism in suppressed interferon beta induction of severe acute respiratory syndrome coronavirus infection.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Significance of the Myxovirus Resistance A (MxA) Gene —123C>A Single-Nucleotide Polymorphism in Suppressed Interferon β Induction of Severe Acute Respiratory Syndrome Coronavirus Infection.
- Published in:
- Journal of Infectious Diseases, 2010, v. 201, n. 12, p. 1899, doi. 10.1086/652799
- By:
- Publication type:
- Article
A Germline Mutation (A339V) in Thyroid Transcription Factor-1 (TITF-1/NKX2. 1) in Patients With Multinodular Goiter and Papillary Thyroid Carcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 3, p. 162, doi. 10.1093/jnci/djn471
- By:
- Publication type:
- Article
Population-based case-control study of HER2 genetic polymorphism and breast cancer risk.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Re: Population-Based Case—Control Study of HER2 Genetic Cancer Risk.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 20, p. 1581, doi. 10.1093/jnci/94.20.1581
- By:
- Publication type:
- Article
Nuclear localization marker of FOXO3a: can it be used to predict doxorubicin response?
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: A differential expression study.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 2, p. 268
- By:
- Publication type:
- Article
Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1411
- By:
- Publication type:
- Article
Malignant placental site trophoblastic tumor.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 8, p. 2288, doi. 10.1002/cncr.10424
- By:
- Publication type:
- Article
Primary peritoneal malignant mixed Müllerian tumors.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 5, p. 1052, doi. 10.1002/1097-0142(20010301)91:5<1052::AID-CNCR1097>3.0.CO;2-A
- By:
- Publication type:
- Article
Coexisting Epithelioid Trophoblastic Tumor and Choriocarcinoma of the Uterus Following a Chemoresistant Hydatidiform Mole.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2003, v. 127, n. 7, p. e291, doi. 10.5858/2003-127-e291-cettac
- By:
- Publication type:
- Article
Regarding 'Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients'.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer.
- Published in:
- Journal of Pathology, 2023, v. 261, n. 2, p. 156, doi. 10.1002/path.6157
- By:
- Publication type:
- Article
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 24, p. 4991, doi. 10.1093/hmg/ddr405
- By:
- Publication type:
- Article
Constitutively Nuclear FOXO3a Localization Predicts Poor Survival and Promotes Akt Phosphorylation in Breast Cancer.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012293
- By:
- Publication type:
- Article
Reply to “Lack of support for an association between CLEC4M homozygosity and protection against SARS coronavirus infection”.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.
- Published in:
- Nature Genetics, 2006, v. 38, n. 1, p. 38, doi. 10.1038/ng1698
- By:
- Publication type:
- Article
Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer.
- Published in:
- PLoS Genetics, 2012, v. 8, n. 2, p. 1, doi. 10.1371/journal.pgen.1002532
- By:
- Publication type:
- Article
Genome-wide association analysis in East Asians identifies breast cancer susceptibility loci at 1q32.1, 5q14.3 and 15q26.1.
- Published in:
- Nature Genetics, 2014, v. 46, n. 8, p. 886, doi. 10.1038/ng.3041
- By:
- Publication type:
- Article
Detection of mitochondrial DNA mutations in gestational trophoblastic disease (Communicated by Mark H. Paalman) Online Citation: Human Mutation, Mutation in Brief #631 (2003) Online http://www.interscience.wiley.com/humanmutation/pdf/mutation/631.pdf).
- Published in:
- Human Mutation, 2003, v. 22, n. 2, p. 177, doi. 10.1002/humu.9160
- By:
- Publication type:
- Article
Detection of mitochondrial DNA mutations in gestational trophoblastic diseaseCommunicated by Mark H. PaalmanOnline Citation: Human Mutation, Mutation in Brief #631 (2003) Onlinehttp://www.interscience.wiley.com/humanmutation/pdf/mutation/631.pdf.
- Published in:
- Human Mutation, 2003, v. 22, n. 2, p. 177, doi. 10.1002/humu.9160
- By:
- Publication type:
- Article
Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population.
- Published in:
- Human Mutation, 2002, v. 19, n. 3, p. 307, doi. 10.1002/humu.9015
- By:
- Publication type:
- Article
Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
- Published in:
- Human Mutation, 2000, v. 16, n. 1, p. 88, doi. 10.1002/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G
- By:
- Publication type:
- Article
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.
- Published in:
- Oncogene, 1999, v. 18, n. 32, p. 4643, doi. 10.1038/sj.onc.1202847
- By:
- Publication type:
- Article
Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
- Published in:
- Journal of Pathology, 2011, v. 224, n. 1, p. 78, doi. 10.1002/path.2859
- By:
- Publication type:
- Article
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.578
- By:
- Publication type:
- Article
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 10, p. 1, doi. 10.1002/ctm2.554
- By:
- Publication type:
- Article
Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 2, p. 296, doi. 10.1002/ijc.23494
- By:
- Publication type:
- Article
CpG/CpNpG motifs in the coding region are preferred sites for mutagenesis in the breast cancer susceptibility genes
- Published in:
- FEBS Letters, 2007, v. 581, n. 24, p. 4668, doi. 10.1016/j.febslet.2007.08.061
- By:
- Publication type:
- Article
SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer.
- Published in:
- Carcinogenesis, 2013, v. 34, n. 7, p. 1476, doi. 10.1093/carcin/bgt098
- By:
- Publication type:
- Article
Modulating the Activity of Androgen Receptor for Treating Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15342, doi. 10.3390/ijms232315342
- By:
- Publication type:
- Article
Checkpoint Kinase 2 Inhibition Can Reverse Tamoxifen Resistance in ER-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12290, doi. 10.3390/ijms232012290
- By:
- Publication type:
- Article